ClinicalTrials.govpublic full text
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
chronic kidney disease and hypertension, chronic kidney disease, hypertension, blood pressure, baxdrostat, dapagliflozin, event-driven, outcome, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 843329
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.